Fiche du document
2023
- doi: 10.3389/fcvm.2023.1102063
- issn: 2297-055X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcvm.2023.1102063
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36742076
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2297-055X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_C97A6A676F214
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Therapy Diseases--ImagingCiter ce document
K. Rezaei-Kalantari et al., « Insights into pelvic venous disorders. », Serveur académique Lausannois, ID : 10.3389/fcvm.2023.1102063
Métriques
Partage / Export
Résumé
Pelvic venous disorders (PeVD), sometimes referred to as pelvic congestion syndrome (PCS), widely impact affected patients-mainly young women's quality of life, causing puzzling, uncomfortable symptoms sometimes requiring months or years to get an explanation, while simply remaining undiagnosed in other cases. Because pelvic pain is a non-specific symptom, an appropriate diagnosis requires a careful patient workup, including a correlation between history and non-invasive imaging. Invasive imaging is frequently required to confirm the diagnosis and plan treatment. Current therapeutic approaches principally rely on minimally invasive techniques delivered through endovascular access. However, while comprehensive descriptive classifications such as the symptoms-varices-pathophysiology (SVP) classification exist, universally accepted guidelines regarding therapy to apply for each SVP category are still lacking. This review strongly focuses on PeVD imaging and discusses available therapeutic approaches with regard to pathophysiological mechanisms. It proposes a new classification scheme assisting clinical decision-making about endovascular management to help standardize the link between imaging findings and treatment.